Immunotherapy for Metastatic Kidney Cancer Shows Increased Survival
2 Ansichten
• 07/10/23
0
0
Einbetten
administrator
Abonnenten
The immune checkpoint inhibitor Opdivo (nivolumab) has been shown to increase survival for patients with metastatic clear cell kidney cancer (also called renal cell carcinoma, or RCC).
Zeig mehr
Facebook Kommentare
SORT BY-
Beste Kommentare
-
Neueste Kommentare